You are here: Industry Insights > Remdesivir

News List

Australia’s TGA approves remdesivir as first Covid-19 treatment pharmaceutical-technology
July 14, 2020
The Therapeutic Goods Administration (TGA) of Australia has awarded provisional approval for the use of Gilead Sciences’ remdesivir (Veklury) to treat Covid-19 patients, marking the first authorisation of treatment for this disease in the country.
Mumbai, Thane to get 60 per cent of Maharashtra’s remdesivir stock expresspharma
July 14, 2020
It is likely that Cipla and Hetero Healthcare will supply 9000 vials and 12500 vials of remdesivir, respectively, to the State this week.
Gujarat government to procure 20,000 vials of remdesivir expresspharma
July 13, 2020
The state government has already placed a bulk order for 8000 tocilizumab injections with Cipla.
Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies needed expresspharma
July 13, 2020
The company, which had initially released the data from the trial in April, said the finding requires confirmation in clinical trials.
‘Indiscriminate use of remdesivir, tocilizumab on Covid patients can cause more harm than good’ expresspharma
July 13, 2020
It said the pursuit of an effective treatment for COVID-19 has resulted in repurposing of several drugs which are not part of the main Clinical Management Protocol but have been indicated as investigational therapies.
Gilead begins PhI trial of inhaled remdesivir pharmatimes
July 10, 2020
Gilead has begun testing an inhalable version of remdesivir in a Phase Ia study, to assess its potential as a treatment for COVID-19.
Gilead begins testing inhalable form of remdesivir for COVID-19 expresspharma
July 10, 2020
The company said the trial will test the drug particularly in those cases where the disease has not progressed to require hospitalization.
Remdesivir can save more lives where ICUs are overwhelmed worldpharmanews
July 08, 2020
Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity ...
Mylan gets approval for emergency use of remdesivir for Covid-19 pharmaceutical-technology
July 08, 2020
Mylan has secured regulatory approval from the Drug Controller General of India (DCGI) for restricted emergency use of 100mg/vial remdesivir lyophilized powder to treat Covid-19.
CDSCO asks drug controllers to take measures against black marketing of remdesivir expresspharma
July 08, 2020
Reportedly, the drug is being sold at exorbitant prices ranging between Rs 15,000 to Rs 60,000.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page